Brian Van Ness, PhD is a professor in the Department of Genetics, Cell Biology and Development, the director of the Precision Medicine Seminar Series for the Minnesota Precision Medicine Collaborative, and a member of the Institute of Personalized Medicine in the College of Pharmacy.
With more than 30 years of experience in academia, Dr. Straka’s interests lie in better understanding pharmacokinetic, pharmacodynamic and pharmacogenomic sources of variability in drug response.
David Stenehjem is a board-certified clinical oncology pharmacist and specializes in oncology outcomes research and clinical research in precision medicine.
The focus of Dr. Oetting’s research is to identify genetic variants associated with complex human phenotypes and disease. Currently, his focus is on the identification of genetic variation associated with various outcomes in kidney allograft recipients, including pharmacogenomic-related outcomes.
Christina Jacobson is a registered nurse at the University of Minnesota Medical Center East Bank in the Neuroscience unit. She attended the University of Minnesota Duluth and then graduated with a bachelor’s degree in nursing from St. Scholastica College of Nursing.
Dr. Huang’s research focuses on translational pharmacogenomics with particular interest in anticancer agents. By systematically evaluating the human genomes and their relationships to drug response and toxicity, her goal is to develop clinically useful models that predict risks for adverse drug reactions and non-response prior to administration of chemotherapy.
Dr. Gregornik received his BS and PharmD from the University of Minnesota College of Pharmacy and completed postdoctoral training at St. Jude Children's Research Hospital in Memphis, TN. Dr. Gregornik spent 18 years in clinical and leadership roles at St. Jude, an early implementer of pharmacogenomics, and three years at Memorial-Sloan Kettering Cancer Center in New York City, where he served as Manager of Pediatric Clinical Pharmacy Programs. Dr.
Dr. Brown’s expertise lies primarily within pediatric pharmacotherapy, pharmacogenetics, pharmacogenomics, and pharmacokinetics.
Dr. Bishop received his biology degree at Luther College in Decorah, Iowa.
For nearly 15 years, Dr. Allen has been a leader in the field of personalized medicine. Throughout his career, he has led multiple scientific efforts including clinical research, product development, and clinical adoption and implementation. He was part of the Mayo Clinic team that developed the GeneSight test, and spent 5 years as a medical science liaison and medical information manager for Assurex Health, which commercialized GeneSight. Dr.
